ESCRS - PO0315 - Acute Severe Bronchospasm Secondary To Intracameral Acetylcholine In Patient With Chronic Obstructive Pulmonary Disease (Copd) After Phacoemulsification.

Acute Severe Bronchospasm Secondary To Intracameral Acetylcholine In Patient With Chronic Obstructive Pulmonary Disease (Copd) After Phacoemulsification.

Published 2023 - 41st Congress of the ESCRS

Reference: PO0315 | DOI: 10.82333/gghp-7x90

Authors: Cristina Montón Giménez 1 , Álvaro Sánchez Ventosa* 2 , María Angélica Henríquez Recine 1 , Katarzyna Kubiak 3 , Eduardo Conesa Hernández 4 , Santiago López García 1

1Hospital Universitario Severo Ochoa,Leganés,Spain, 2Hospital La Arruzafa,Córdoba,Spain, 3Hospital Niño Jesús,Madrid,Spain, 4Hospital Infanta Sofía,San Sebastián de los Reyes,Spain

Report a very rare systemic bronchoconstrictor effect of anticholinergics when they are used locally (intracameral).

Hospital Universitario Severo Ochoa

A clinical case is described of a patient with obesity, diabetes mellitus, severe COPD with high risk of chronic respiratory failure and severe sleep apnea and hypopnea syndrome with continuous positive airway pressure. Phacoemulsification and intraocular lens in capsular bag was performed. There was a mild complication that required the use of intracameral acetylcholine.

After initiating oral tolerance, the patient developed acute and spontaneous severe bronchospasm with poor response to inhaled bronchodilators with desaturation up to 70%, requiring orotracheal intubation.

It is important to consider the bronchoconstrictor effect of anticholinergics when using intracerular acetylcholine during phacoemulsification in COPD patients at high risk of exacerbation.